Study for predictors of response to infliximab therapy for ulcerative colitis

Study for predictors of response to infliximab therapy for ulcerative colitis - Study for predictors of response to infliximab therapy for ulcerative colitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007256

Enrollment

Registered

2012-02-10

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Ulcerative colitis (moderate-to-severe)

Exclusion criteria

Exclusion criteria: 1)Patient whose age below 16 years old 2)Patients who cannot been kept in the treatment with infliximab (Patients with serious infection, active tuberculosis, history of allergy to ingredients of infliximab or to proteins derived from mouse, demyelinating diseases and its past history, congestive heart failure) 3)Patients who are pregnant 4)Patients who are inadequate to enter this trial due to the other reasons by physician's judgments

Design outcomes

Primary

Measure	Time frame
Remission rate at week 10 and 54 (Lichitiger index)	—

Countries

Japan

Outcome results